Synopsis
Synopsis
0
VMF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Apo Pravastatin
2. Apo-pravastatin
3. Bristacol
4. Cs 514
5. Cs-514
6. Cs514
7. Elisor
8. Eptastatin
9. Lin Pravastatin
10. Lin-pravastatin
11. Lipemol
12. Liplat
13. Lipostat
14. Mevalotin
15. Nu Pravastatin
16. Nu-pravastatin
17. Prareduct
18. Pravachol
19. Pravacol
20. Pravasin
21. Pravastatin
22. Pravastatin Monosodium Salt, (6 Beta)-isomer
23. Pravastatin Sodium Salt
24. Pravastatin Tert Octylamine Salt
25. Pravastatin Tert-octylamine Salt
26. Pravastatin, (6 Beta)-isomer
27. Rms 431
28. Rms-431
29. Rms431
30. Selektine
31. Sodium Salt, Pravastatin
32. Sq 31,000
33. Sq 31000
34. Sq-31,000
35. Sq-31000
36. Sq31,000
37. Sq31000
38. Vasten
1. 81131-70-6
2. Pravachol
3. Mevalotin
4. Selektine
5. Elisor
6. Pravaselect
7. Lipostat
8. Eptastatin Sodium
9. Cs-514
10. Pravastatin Sodium Salt
11. Pravastatin (sodium)
12. Dehypotin Protect
13. Sq-31000
14. Sq-31,000
15. Chebi:8361
16. Bristacol
17. Lipemol
18. Prareduct
19. Pravacol
20. Pravasin
21. 3m8608uq61
22. Nsc-759253
23. Sodium;(3r,5r)-7-[(1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
24. Aplactin
25. Lipidal
26. Liprevil
27. Pralidon
28. Pravasine
29. Sanaprav
30. Selipran
31. Vasen
32. Epastatin Sodium
33. Dsstox_cid_27525
34. Dsstox_rid_82395
35. Dsstox_gsid_47525
36. Liplat
37. Vasten
38. Pravastatin, Sodium Salt
39. (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-(((s)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic Acid, Sodium Salt
40. Cas-81131-70-6
41. Pravastatin Natrium Mayrho Fer
42. Sq 31000
43. 3-beta-hydroxycompactin Sodium Salt
44. Drg-0319
45. Chembl690
46. Unii-3m8608uq61
47. Cres Pravastatin
48. Pravachol (tn)
49. Ncgc00095183-01
50. Pravastatin Sodium [usan:usp:jan]
51. Mfcd00887601
52. Pravastatinsodium,(s)
53. Cs-514 Sodium
54. Pravastatin Sodium- Bio-x
55. Schembl3013
56. Sodium (+)-(betar,deltar,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2s)-2-methylbutyrate)
57. Pravastatin Sodium [mi]
58. Dtxsid6047525
59. Pravastatin Sodium [jan]
60. Hy-b0165a
61. Pravastatin Sodium (jp17/usp)
62. Pravastatin Sodium [usan]
63. Hms2051p05
64. Hms3268l20
65. Hms3413e20
66. Pravastatin Sodium [vandf]
67. Hexahydronaphthalen-1-yl)heptanoate
68. Pravastatin Sodium [mart.]
69. Amy40517
70. Pravastatin Sodium [usp-rs]
71. Pravastatin Sodium [who-dd]
72. Tox21_111474
73. Tox21_300270
74. S3036
75. Akos015896504
76. Akos015964902
77. Ccg-100926
78. Cs-2003
79. Nc00176
80. Nsc 759253
81. Pravastatin Sodium [orange Book]
82. Ncgc00092370-01
83. Ncgc00254232-01
84. Pravastatin Sodium [ep Monograph]
85. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, Monosodium Salt, (1s-(1-alpha(beta-s*,delta-s*),2-alpha,6-alpha,8-beta(r*),8a-alpha))-
86. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, Monosodium Salt, (1s-(1alpha(betas*,deltas*),2alpha,6alpha,8beta(r*),8aalpha))-
87. Bp164292
88. Pravastatin Sodium [usp Monograph]
89. P1796
90. D00893
91. Pravigard Pac Component Pravastatin Sodium
92. Pravastatin Sodium Component Of Pravigard Pac
93. Q27108059
94. Pravastatin Sodium Salt Hydrate, >=98% (hplc), Powder
95. 2-methyl-8-((s)-2-methylbutanoyloxy)-1,2,6,7,8,8a-
96. Sodium (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-
97. (?r,?r,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2s)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic Acid Monosodium Salt
98. (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-(((s)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoicacid,sodiumsalt
99. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-.beta.,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, Monosodium Salt, (1s-(1.alpha.(.beta.s*,ds*),2.alpha.,6.alpha.,8.beta.(r*),8a.alpha.))-
100. Sodium (+)-(.beta.r,dr,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-.beta.,d,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2s)-2-methylbutyrate)
101. Sodium (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-((s)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
102. Sodium (3r,5r)-3,5-dihydroxy-7-[(1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
Molecular Weight | 446.5 g/mol |
---|---|
Molecular Formula | C23H35NaO7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 11 |
Exact Mass | 446.22804773 g/mol |
Monoisotopic Mass | 446.22804773 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 662 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Pravachol |
PubMed Health | Pravastatin (By mouth) |
Drug Classes | Antihyperlipidemic |
Drug Label | PRAVACHOL (pravastatin sodium) is one of a class of lipid-lowering compounds, the statins, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of HMG-CoA reductase, the enzyme catalyzing the early rate-limiting step in ch... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
2 of 4 | |
---|---|
Drug Name | Pravastatin sodium |
Drug Label | Pravastatin sodium tablets are one of a class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase,... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Teva; Lupin Pharms; Apotex; Sandoz; Cipla; Watson Labs; Glenmark Generics; Teva Pharms; Pliva Hrvatska Doo; Zydus Pharms Usa; Dr Reddys Labs; Mylan |
3 of 4 | |
---|---|
Drug Name | Pravachol |
PubMed Health | Pravastatin (By mouth) |
Drug Classes | Antihyperlipidemic |
Drug Label | PRAVACHOL (pravastatin sodium) is one of a class of lipid-lowering compounds, the statins, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of HMG-CoA reductase, the enzyme catalyzing the early rate-limiting step in ch... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
4 of 4 | |
---|---|
Drug Name | Pravastatin sodium |
Drug Label | Pravastatin sodium tablets are one of a class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase,... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Teva; Lupin Pharms; Apotex; Sandoz; Cipla; Watson Labs; Glenmark Generics; Teva Pharms; Pliva Hrvatska Doo; Zydus Pharms Usa; Dr Reddys Labs; Mylan |
Anticholesteremic Agents
Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
26
PharmaCompass offers a list of Pravastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pravastatin manufacturer or Pravastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pravastatin manufacturer or Pravastatin supplier.
PharmaCompass also assists you with knowing the Pravastatin API Price utilized in the formulation of products. Pravastatin API Price is not always fixed or binding as the Pravastatin Price is obtained through a variety of data sources. The Pravastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PRAVIGARD PAC (COPACKAGED)-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PRAVIGARD PAC (COPACKAGED)-1, including repackagers and relabelers. The FDA regulates PRAVIGARD PAC (COPACKAGED)-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PRAVIGARD PAC (COPACKAGED)-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of PRAVIGARD PAC (COPACKAGED)-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A PRAVIGARD PAC (COPACKAGED)-1 supplier is an individual or a company that provides PRAVIGARD PAC (COPACKAGED)-1 active pharmaceutical ingredient (API) or PRAVIGARD PAC (COPACKAGED)-1 finished formulations upon request. The PRAVIGARD PAC (COPACKAGED)-1 suppliers may include PRAVIGARD PAC (COPACKAGED)-1 API manufacturers, exporters, distributors and traders.
click here to find a list of PRAVIGARD PAC (COPACKAGED)-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A PRAVIGARD PAC (COPACKAGED)-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of PRAVIGARD PAC (COPACKAGED)-1 active pharmaceutical ingredient (API) in detail. Different forms of PRAVIGARD PAC (COPACKAGED)-1 DMFs exist exist since differing nations have different regulations, such as PRAVIGARD PAC (COPACKAGED)-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A PRAVIGARD PAC (COPACKAGED)-1 DMF submitted to regulatory agencies in the US is known as a USDMF. PRAVIGARD PAC (COPACKAGED)-1 USDMF includes data on PRAVIGARD PAC (COPACKAGED)-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PRAVIGARD PAC (COPACKAGED)-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of PRAVIGARD PAC (COPACKAGED)-1 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The PRAVIGARD PAC (COPACKAGED)-1 Drug Master File in Japan (PRAVIGARD PAC (COPACKAGED)-1 JDMF) empowers PRAVIGARD PAC (COPACKAGED)-1 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the PRAVIGARD PAC (COPACKAGED)-1 JDMF during the approval evaluation for pharmaceutical products. At the time of PRAVIGARD PAC (COPACKAGED)-1 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of PRAVIGARD PAC (COPACKAGED)-1 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a PRAVIGARD PAC (COPACKAGED)-1 Drug Master File in Korea (PRAVIGARD PAC (COPACKAGED)-1 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of PRAVIGARD PAC (COPACKAGED)-1. The MFDS reviews the PRAVIGARD PAC (COPACKAGED)-1 KDMF as part of the drug registration process and uses the information provided in the PRAVIGARD PAC (COPACKAGED)-1 KDMF to evaluate the safety and efficacy of the drug.
After submitting a PRAVIGARD PAC (COPACKAGED)-1 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their PRAVIGARD PAC (COPACKAGED)-1 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of PRAVIGARD PAC (COPACKAGED)-1 suppliers with KDMF on PharmaCompass.
A PRAVIGARD PAC (COPACKAGED)-1 CEP of the European Pharmacopoeia monograph is often referred to as a PRAVIGARD PAC (COPACKAGED)-1 Certificate of Suitability (COS). The purpose of a PRAVIGARD PAC (COPACKAGED)-1 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of PRAVIGARD PAC (COPACKAGED)-1 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of PRAVIGARD PAC (COPACKAGED)-1 to their clients by showing that a PRAVIGARD PAC (COPACKAGED)-1 CEP has been issued for it. The manufacturer submits a PRAVIGARD PAC (COPACKAGED)-1 CEP (COS) as part of the market authorization procedure, and it takes on the role of a PRAVIGARD PAC (COPACKAGED)-1 CEP holder for the record. Additionally, the data presented in the PRAVIGARD PAC (COPACKAGED)-1 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the PRAVIGARD PAC (COPACKAGED)-1 DMF.
A PRAVIGARD PAC (COPACKAGED)-1 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. PRAVIGARD PAC (COPACKAGED)-1 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of PRAVIGARD PAC (COPACKAGED)-1 suppliers with CEP (COS) on PharmaCompass.
A PRAVIGARD PAC (COPACKAGED)-1 written confirmation (PRAVIGARD PAC (COPACKAGED)-1 WC) is an official document issued by a regulatory agency to a PRAVIGARD PAC (COPACKAGED)-1 manufacturer, verifying that the manufacturing facility of a PRAVIGARD PAC (COPACKAGED)-1 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting PRAVIGARD PAC (COPACKAGED)-1 APIs or PRAVIGARD PAC (COPACKAGED)-1 finished pharmaceutical products to another nation, regulatory agencies frequently require a PRAVIGARD PAC (COPACKAGED)-1 WC (written confirmation) as part of the regulatory process.
click here to find a list of PRAVIGARD PAC (COPACKAGED)-1 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PRAVIGARD PAC (COPACKAGED)-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for PRAVIGARD PAC (COPACKAGED)-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture PRAVIGARD PAC (COPACKAGED)-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain PRAVIGARD PAC (COPACKAGED)-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PRAVIGARD PAC (COPACKAGED)-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of PRAVIGARD PAC (COPACKAGED)-1 suppliers with NDC on PharmaCompass.
PRAVIGARD PAC (COPACKAGED)-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PRAVIGARD PAC (COPACKAGED)-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PRAVIGARD PAC (COPACKAGED)-1 GMP manufacturer or PRAVIGARD PAC (COPACKAGED)-1 GMP API supplier for your needs.
A PRAVIGARD PAC (COPACKAGED)-1 CoA (Certificate of Analysis) is a formal document that attests to PRAVIGARD PAC (COPACKAGED)-1's compliance with PRAVIGARD PAC (COPACKAGED)-1 specifications and serves as a tool for batch-level quality control.
PRAVIGARD PAC (COPACKAGED)-1 CoA mostly includes findings from lab analyses of a specific batch. For each PRAVIGARD PAC (COPACKAGED)-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PRAVIGARD PAC (COPACKAGED)-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (PRAVIGARD PAC (COPACKAGED)-1 EP), PRAVIGARD PAC (COPACKAGED)-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PRAVIGARD PAC (COPACKAGED)-1 USP).